Comparison of pegylated interferon monotherapy and de novo pegylated interferon plus tenofovir combination therapy in patients with chronic hepatitis B

Background and aim: We aimed to evaluate the effectiveness of pegylated interferon (Peg-IFN) monotherapy (IFN group) and combination therapy with tenofovir (TDF) and Peg-IFN (IFN+TDF group) in chronic hepatitis B (CHB) patients. Patients and methods: Data of 143 CHB patients were analyzed in this st...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Caixia, Yan, Honghong, Zeng, Jianyong, Cai, Shaohang, Wu, Xiaolu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6489617/
https://www.ncbi.nlm.nih.gov/pubmed/31114265
http://dx.doi.org/10.2147/IDR.S195144

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6489617/
https://www.ncbi.nlm.nih.gov/pubmed/31114265
http://dx.doi.org/10.2147/IDR.S195144

Ejemplares similares